Cell & Gene Therapy 2021
Where: 04
Mogrify has developed a proprietary suite of technology platforms that enable systematic identification of the key transcriptomic and epigenetic switches that drive the speed, efficiency and maintenance of cell reprogramming for the development of cell therapies and in vivo reprogramming therapies.

MOGRIFY® is a direct cellular reprogramming technology that utilizes a systematic big-data approach (Rackham et al., Nature Genetics, 2016) that deploys next-generation sequencing and gene regulatory data to enable the prediction of the transcription factors (or small molecules) required to produce (ex vivo or in vivo) any target cell type from any source cell type.

epiMOGRIFY is a cell identity platform, which leverages epigenetic data to identify optimal combinations of transcription factors or growth factors required to maintain cell identity and epigenetically support the conversion of cells in chemically defined media.

These platforms are being deployed to develop scalable ex vivo cell therapies and in vivo reprogramming therapies for immuno-oncology, ophthalmology and other disease areas with a high unmet clinical need.

Learn more about our technology: mogrify.co.uk/science/mogrify/
Tel: 01223734154
Address: 25 Cambridge Science Park Milton Road
Website: https://www.mogrify.co.uk
Email: info@mogrify.co.uk

Presentations at Cell & Gene Therapy 2021

Staff Attending

Mr Mark Cavanagh
Marketing Director
Ms Betty Hou
Marketing Associate
Mogrify Limited
Dr Karin Schmitt

Find out more...

To view the virtial stand - please login first Brochure Defining Cell Culture Conditions to Drive Cell Identity and Scalability in Cell Therapy

Brochure Realizing Retinal Regeneration

Brochure Computational Tools for Accelerating Regenerative Medicine

Brochure CELL THERAPY falling short of its potential?

Webinar | A Systematic Approach for Driving Cell Identity and Accelerating Regenerative Medicine

Webinar | The Epigenetics Approach to Driving Cell Identity and Scalability in Cell Therapy

LinkedIn URL